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Viral incorporationRetroviral envelope glycoproteins undergo proteolytic processing by cellular subtilisin-like proprotein con-
vertases at a polybasic amino-acid site in order to produce the two functional subunits, SU and TM.Most previous
studies have indicated that envelope-protein cleavage is required for rendering the protein competent for
promoting membrane fusion and for virus infectivity. We have investigated the role of proteolytic processing of
theMoloneymurine leukemia virus envelope-protein through site-directedmutagenesis of the residues near the
SU–TM cleavage site and have established that uncleaved glycoprotein is unable either to be incorporated into
virus particles efﬁciently or to induce membrane fusion. Additionally, the results suggest that cleavage of the
envelope protein plays an important role in intracellular trafﬁcking of protein via the cellular secretory pathway.
Based on our results it was concluded that a positively charged residue located at either P2 or P4 along with the
arginine at P1 is essential for cleavage.Sciences, West Lafayette, IN
ir@purdue.edu (D.A. Sanders).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Many cellular and viral proteins are synthesized as proproteins that
undergo proteolytic processing by cellular endoproteases to become
functionally mature. One of the viral proteins that are proteolytically
matured is the retrovirus envelope glycoprotein (Env). Env is cleaved
by cellular proprotein convertases (PCs) of the serine-endoproteinase
family to produce two subunits—SU, an extracellular glycoprotein
responsible for binding to viral receptors, and TM, a transmembrane
protein responsible for tethering Env complexes to viral particles and
inducing fusion between viral and cellular membranes (Cofﬁn et al.,
1997).
The requirement for the proteolytic processing of the envelope
protein in retroviruses has previously been studied by several groups.
For many years cleavage was speculated to be essential, because it
liberates the fusion peptide located at the amino-terminus of the
transmembrane subunit (Cofﬁn et al., 1997; McCune et al., 1988). The
fusion peptide induces membrane fusion between the target cell
membrane and the virusmembrane leading to virus entry into the cell.
Via manipulations of the enzyme-recognition sequence, several
studies have demonstrated in retroviruses that cleavage is essential
for virus infectivity and membrane fusion in murine leukemia viruses
(MLVs) (Famulari and Jelalian, 1979; Freed and Risser, 1987; Granowitz
et al., 1991; Machida and Kabat, 1982; Zavorotinskaya and Albritton,1999), in human immunodeﬁciency virus type 1 (HIV-1) (Bosch and
Pawlita, 1990; Dubay et al., 1995; Freed et al., 1989; Guo et al., 1990;
Kleny et al., 1988; McCune et al., 1988), in Rous sarcoma virus (RSV)
(Dong et al., 1992; Perez and Hunter, 1987) and in mouse mammary
tumor virus (MMTV) (Goodman et al., 1993). Some studies have shown
that cleavage is not required for the envelope protein export to the
cell surface but is required for incorporation of Env in the virus particles
(Dubay et al., 1995; Kleny et al., 1988), while others demonstrated that
it is a prerequisite neither for transport to the cell surface nor for its
incorporation into virus particles (Dong et al., 1992; Famulari and
Jelalian, 1979; Guo et al., 1990; Herrera et al., 2005; Machida and Kabat,
1982; Zavorotinskaya and Albritton, 1999) or for virus infectivity
(Machida and Kabat, 1982; Zavorotinskaya and Albritton, 1999). Here,
as an attempt to resolve these contradictory ﬁndings, we have con-
ducted an extensive systematic study of the role of cleavage motif of
the Moloney murine leukemia virus (Mo-MuLV) Env in its trafﬁcking,
incorporation in the virus particles and membrane fusion.
The envelope glycoprotein of Mo-MuLV is initially synthesized as
a 665 amino-acid precursor protein (Shinnick et al., 1981) that is
cotranslationally inserted in the membrane of the endoplasmic
reticulum (ER). In the ER lumen, high mannose sugars are added to
the asparagine residues, intersubunit disulﬁde bonds are formed, and
the protein is trimerized via a coiled-coil located in the TM subunit
(Kamps et al., 1991). In the Golgi cisternae, the N-linked sugar residues
are modiﬁed into complex oligosaccharide chains, and O-linked sugars
are added. Finally, in the trans-Golgi network (TGN) Env is proteolyt-
ically cleaved by cellular furin or furin-like proprotein convertases
(Basak et al., 2001; Bedgood and Stallcup, 1992; Henderson et al., 1984;
Schultz and Rein, 1985; Shinnick et al., 1981;Witte et al., 1977) into two
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residues. The minimum enzyme-recognition sequence for most
proprotein convertases is Arg-X-Lys/Arg-Arg↓Y (P4-P3-P2-P1↓P1′ re-
spectively, where ↓ represents cleavage, X represents any residue and Y
represents any nonhydrophobic residue) (Henrich et al., 2003, 2005;
Rockwell and Fuller, 1998; Rockwell and Fuller, 2002; Rockwell et al.,
2002; Rockwell and Thorner, 2004; Schechter and Berger, 1968). After
cleavage, the two subunits remain attached covalently resulting in
the formation of trimers of SU–TM complexes (Opstelten et al., 1998;
Pinter and Fleissner, 1977; Pinter et al., 1997; Sanders, 2000). The virus
acquires these Envcomplexes alongwith the lipid bilayerwhile budding
through cellular membranes. In the budded virus the viral proteaseFig. 1.Mo-MuLV envelope protein cleavage-motif. ↓ represents cleavage site. (A) The positio
amino-acid number in the sequence of Moloney murine leukemia virus envelope protein
envelope proteins: The cell lysates from ΦNXnlslacZ cells expressing wild-type or mutan
transferred to the nitrocellulose membranes and probed with α-SU (anti-Raucher gp70 ant
separately. Three species of Env are detected by anti-SU antibody: gPr90env (90 kDa) fully N
mannose glycosylated Env, and gp70 (SU) (70 kDa); their positions of migration are indicat
Anti-capsid antibody recognizes Pr65Gag protein (65 kDa). (G and H) Immunoblot analysi
acrylamide gradient gels. A 15 kDa p15E (TM) band is detected by the monoclonal anti-TM
transfected with empty vector. In the α-SU panel of B, a small volume of protein from thecleaves the last 16 amino acids (the R-Peptide) from the C-terminus of
Env thereby disrupting a domain that inhibits fusion by Env in the virus-
producing cells (Aguilar et al., 2003; Januszeski et al., 1997; Ragheb and
Anderson, 1994; Rein et al., 1994; Taylor and Sanders, 2003).
We have investigated the role of proteolytic processing in the func-
tion of the envelope protein in Mo-MuLV. The proprotein-convertases
recognition site is highly conserved among retroviruses. By engineering a
series of substitution mutations in the enzyme recognition sequence we
haveobtainedevidence that cleavage is indeedessential for virus-induced
membrane fusion and envelope glycoprotein incorporation into virions.
Additionally, ourﬁndings suggest that cleavage plays an important role in
the intracellular trafﬁcking of the glycoprotein.ns of the amino-acid residues in the cleavage motif are represented above them and the
is represented in subscript. (B-F) Analysis of the proteolytic processing of Mo-MuLV
t envelope proteins were analyzed by SDS-PAGE (9% acrylamide). The proteins were
ibody) (B-F upper panels) and α-CA (anti-p30 antibody) antibodies (B-F lower panels)
- and O-glycosylated and uncleaved Env, gPr80env (80 kDa), an endo-H sensitive, high
ed on the right. Molecular size marker is represented on the left with the sizes in kDa.
s using α-TM antibody was performed. The cell lysates were analyzed using 10-20%
antibody. ‘wt’ represents wild-type envelope protein and ‘m’ (mock) represents cells
wt lane has leaked into the mock lane.
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In order to study the roles cleavage-motif residues Arg466–His467–
Lys468–Arg469↓Glu470 (Shinnick et al., 1981) (Fig. 1A) play in substrate
recognition by PCs, and the effect of defective processing on Env
function, substitution mutations were created for P4, P2, P1 or P1′
codons in env. The processing and level of virion incorporation of each
mutant Env was investigated, and its capacity to promote membrane
fusion and viral transduction was assayed.
The P1 residue is critical along with a P2 or P4 basic residue for efﬁcient
cleavage
In order to determine if the mutations created at the cleavage
motif affect the proteolytic processing of the envelope protein,
ΦNXnlslacZ cells (HEK293T cells stably transfected with (Mo-MuLV)
gag and pol genes and a retroviral vector carrying the lacZ gene (Taylor
and Sanders, 1999) were transfected with the plasmids encoding
either wild-type or mutant Env. After 48h, the cell lysates were
harvested and subjected to immunoblot analysis using goat anti-SU
polyclonal antibody. Immunoreactive proteins that are present in
the lysates of the cells expressing wild-type Env display apparent
molecular weights of 80 kDa and 70 kDa representing endoglycosi-
dase H (endo H) sensitive, high-mannose glycans carrying gPr80env
and mature SU (gp70) respectively (Figs. 1B–F), as shown previously
(Kayman et al., 1991; Witte and Wirth, 1979). Proteins with
substitutions for P4 (R466) or P2 (K468) with another basic residue
were cleaved at a level close to wild-type (Figs. 1B and C). Cleavage of
proteins with substitutions for P2 and P4 with alanine or glycine was
reduced as indicated by the presence of immunoreactive uncleaved,
endo-H resistant N- and O-glycosylated Env (gPr90env) of ∼90 kDa,
whereas substitution of either with glutamate reduced cleavage to an
almost undetectable level (Figs. 1B and C). Moreover, we examined
the effects of substitution mutations created at position P1′ (E470).
We found that substitution with an aspartate did not affect the
cleavage. An alanine, glycine or glutamine at P1′ made the protein
less sensitive to cleavage and a lysine at P1′ completely abolished the
cleavage (Fig. 1D). In contrast, in the lysates of the cells expressing
Envs with substitutions at P1 (R469), the antibody detected only the
80- and 90-kDa species (Fig. 1E). Further, to investigate whether a
basic residue is required at one or the other of the P2 and P4 positions,
we created paired mutants where both the residues were simulta-
neously substituted with alanine, glycine or glutamate. Interestingly,
all the paired mutants were found to be uncleaved (Fig. 1F).
These results were conﬁrmed by an immunoblot assay using anti-
TM monoclonal antibody. TM (P15E, ∼15 kD) was detected in the
lysates of cells expressingmutants for which evidence of Env cleavage
was observed (Figs. 1G and H), but not in those of cells expressing
uncleaved Env (Figs. 1G and H).
In order to verify the identiﬁcation of the immunoreactive wild-
type and mutant proteins in the cell lysates, the proteins present
in them were treated with PNGaseF, a deglycosylase that removes
all N-linked sugars from proteins. Cell lysates were collected and half
of each lysate was treated with PNGaseF. The samples were each
analyzed by immunoblot assay using the anti-SU antibody (Fig. 2).
After removal of N-linked oligosaccharides, the gPr90env and Pr80env
migrate with apparent molecular weight of 72 kDa (Pr72env) and
68 kDa (Pr68env) respectively, as shown previously (Bedgood and
Stallcup, 1992; Witte and Wirth, 1979). The cleavage product SU
(gp70) when stripped of N-linked oligosaccharides has an apparent
molecular weight of 50 kDa. Immunoblot analysis of cleavage-
defective mutant proteins indicated the presence of the 72 kDa and
68 kDa species (Figs. 2A and B), whereas in the analysis of wild-type
protein the 68 kDa and 50 kDa species were found (Figs. 2A and B, wt).
This conﬁrms that only gPr90env and Pr80env species are present in the
cell lysates expressing cleavage-defective mutants. All three species,72 kDa, 68 kDa and 50 kDa,were seen in immunoblots of incompletely
cleaved mutant proteins such as K468A and R466A indicating the
presence of all three formsof the envelope protein (Fig. 2A). These data
conﬁrm our analysis of the glycosylated mutant envelope proteins.Uncleaved envelope protein is unable to promote transduction
To measure the titer of infectious virus particles produced from
the cells transfected with plasmids encoding envelope proteins
carrying substitutions at the cleavage site, a transduction assay was
performed. Plasmids encoding the mutant envelope proteins were
transiently transfected into ΦNXnlslacZ cells. These cells produce
virus particles containing a recombinant β-galactosidase-encoding
genome; transduction by the recombinant virus from cells trans-
fected with functional envelope proteins results in β-galactosidase
production in the transduced cells. Viruses produced from cells
expressing envelope proteins bearing substitutions for P1, except for
R469K, were unable to transduce cells (Table 1). Transduction by
viruses bearing R466A, R466G, K468A, or K468G Envs were reduced
four-fold compared to wild-type Env-bearing virus, whereas trans-
duction by viruses bearing R466E or K468E Envs was reduced by
greater than thirty to sixty-fold. Transduction by viruses bearing
E470A, E470G or E470Q Envs was reduced approximately 2.5 to 4-
fold, whereas the E470K Env was unable to promote transduction.
Furthermore, the viruses produced from the cells expressing any of
the Envs bearing paired substitutions for P2 and P4 were unable to
transduce. In summary, our data provide evidence that the envelope
proteins that were found to be uncleaved exhibited signiﬁcantly
reduced efﬁciency to transduce, whereas the transduction efﬁciency
of efﬁciently cleaved mutant Envs was not affected by the mutations.
Therefore, we can conclude that SU–TM cleavage is required for
virus transduction.Uncleaved glycoprotein is not incorporated into virus particles
Although SU–TM cleavage was clearly required for the promo-
tion of membrane fusion, we also wanted to examine whether the
substitutions affected Env incorporation into particles or receptor
binding. Previously, it has been demonstrated in MLV (Famulari and
Jelalian, 1979; Zavorotinskaya and Albritton, 1999) and other retro-
viruses such as lentiviruses (Dubay et al., 1995) and avian retro-
viruses (Perez and Hunter, 1987) that the Env precursor can be
incorporated into virions. Here, Env incorporation was investigated
through immunoblot assays using anti-SU and anti-TM antibodies
along with anti-capsid antibody (to measure the level of production
of recombinant virus particles) conducted on virus collected from
the supernatant medium of ΦNXnlslacZ cells expressing the mutant
Envs. There is a general correlation between the levels of cleavage
of the mutant Envs (Figs. 1B and D) and the level of incorporation of
SU into viral particles (Figs. 3A–C). It is noteworthy, nevertheless
that some mutant Envs, such as the R466A, R466G, K468A, and
K468G Envs appear to be relatively efﬁciently incorporated into viral
particles after cleavage despite inefﬁcient processing. Uncleaved
envelope proteins such as those containing substitutions for P1
(except for R469K) or paired substitutions for both P2 and P4 were
not incorporated into virus particles (Figs. 3D and E) indicated by
the absence of proteins immunoreactive with anti-SU. In immuno-
blots using anti-TM antibody, full-length TM (p15E) and TM with
the R-peptide removed (p12E) were detected when viruses bearing
cleaved Env were analyzed (Fig. 3F). No immunoreactive proteins
were detected when virus bearing uncleaved Env proteins was an-
alyzed. Collectively, these results provide strong evidence that pro-
teolytic processing is required for glycoprotein incorporation into
the Mo-MuLV virion.
Fig. 2. Deglycosylation assay using PNGaseF. Cell lysates of ΦNXnlslacZ expressing wild-type and mutant envelope proteins, treated with PNGaseF (PNGaseF +) and untreated
(PNGaseF -) were analyzed by SDS-PAGE (9% acrylamide), transferred onto a nitrocellulose membrane and probed with anti-SU antibody. The positions of migration of PNGaseF
untreated proteins are indicated on the left and the positions of deglycosylated Pr72env (72 kDa), Pr68env (68 kDa) and gp50 (SU) (50 kDa) are indicated on the right. Molecular size
marker is also indicated on the left. Mock represents cells transfected with empty vector.
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membrane fusion
Next, the ability of the mutant envelope proteins to induce mem-
brane fusion was examined. In Mo-MuLV, the envelope protein lackingTable 1
Transduction of NIH 3 T3 cells by virions bearing mutant Mo-MuLV envelope protein.
Env Mutants Virus Titer (Transducing units per ml TU/ml)
Wild-type 6.0±0.4×106
Neg. Cont. b3
R466A 1.4±0.2×106
R466G 1.5±0.5×106
R466E 1.0±0.2×105
R466K 6.0±0.3×106
K468A 1.8±0.4×106
K468G 1.6±0.2×106
K468E 2.0±0.5×105
K468R 5.8±0.1×106
R469A b3
R469G b3
R469E b3
R469L b3
R469K 2.3±0.3×106
E470A 2.7±1.0×106
E470D 6.1±0.8×106
E470G 2.5±0.6×106
E470K b3
E470Q 1.7±0.2×106
ΦNXnlslacZ cells were transiently transfected with the plasmids encoding the various
mutant envelope proteins. After 48 h the supernatant mediumwas used for transduction
of NIH 3 T3 cells. Transduced cells express β-galactosidase that was detected by X-gal
staining. Virus titer is given as transducing units perml (TU/ml). Transduction units perml
was calculated by multiplying the% blue cells by total number of cells divided by total
volume of virus-containing media (in ml).the R-peptide induces receptor-mediated membrane fusion in NIH 3 T3
cells, forming syncytia (Kubo and Amanuma, 2003; Kubo et al., 2007;
Ragheb andAnderson, 1994; Rein et al., 1994; Taylor andSanders, 2003).
To mimic the mature, fusion-inducing envelope protein the last 16
amino-acid residues from the C-terminus of the mutant envelope
proteinswere deleted (Taylor and Sanders, 1999). Toexamine theability
of various mutants to promote membrane fusion, a syncytia-formation
assay was performed (Table 2). Plasmids encoding themutant envelope
proteinswere transiently transfected intoNIH3 T3 cells, and thenumber
of syncytia and the number of nuclei per syncytia were counted to
calculate the efﬁciency of syncytia formation relative to wild-type
envelope protein lacking the last 16 residues. Any change at P1 caused
complete abrogationofmembrane-fusionpromotion.R466A/Δ650–665
and K468A/Δ650–665 Envs induced moderately reduced numbers of
syncytia, whereas R466K/Δ650–665 and K468R/Δ650–665 Envs in-
duced syncytia formation at levels comparablewith that of thewild-type
Env. Surprisingly, the R466G/Δ650–665, K468G/Δ650–665, R466E/
Δ650–665 andK468E/Δ650–665 Envs induced syncytia formation to an
undetectable level, although the virus bearing these mutant proteins
mediated substantial levels of transduction.
As expected all six paired substitutions completely inhibited
syncytia formation (data not shown). E470G/Δ650–665 and E470Q/
Δ650–665 Envs exhibited reduced capacity to induce syncytia
formation, whereas no syncytia were detected in the case of E470K/
Δ650–665. Collectively, these results indicate that cleavage between
SU and TM is required for membrane fusion in Mo-MLV.
Efﬁciency of cleavage of mutant Envs in human and mouse cells
The discrepancy in our results that R466G and K468G Envs did not
produce any syncytia but promoted a signiﬁcant level of transduction
was addressed by analyzing the processing of the mutant envelope
Fig. 3. Analysis of the viral incorporation of mutant envelope proteins bearing substitutions for the proprotein convertase cleavage site. Virus particles budded fromΦNXnlslacZ cells
expressing wild-type or mutant envelope proteins were collected and analyzed by SDS-PAGE (9% acrylamide) and probed with (A-E) α-SU (anti-Raucher gp70 antibody) and α-CA
(anti-p30 antibody) antibodies separately, and (F) α-TM and α-CA antibodies. The migration of the molecular mass markers are indicated on the left and the positions of gp70 (SU)
(70 kDa) and p30 (CA) (A-E), and two forms of TM, p15E (full-length TM) and p12E (TM lacking the R-peptide), along with p30 (CA) (30 kDa) (F) are indicated on the right. ‘m’
(mock) represents cells transfected with empty vector.
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performed inmouse NIH 3T3 cells using the envelope proteins lacking
the R-peptide, the transduction assay was performed in human 293T
cells using full-length envelope proteins. The cell lysates of NIH 3T3
expressing the mutant Envs carrying the full-length C-terminus or
lacking the R-peptide were probed with goat anti-SU antibody. It was
found that the mature SU (70 kDa) is absent in the lysate of cells
expressing R466G/Δ650–665, whereas it is present in the lysate of the
cells expression R466G (Fig. 4A). Similar results were obtained for
K468G/Δ650–665 and K468G (data not shown). R466E/Δ650–665
and R466E on the other hand are both found to be uncleaved (Fig. 4A).
These results indicate that the Δ650–665 envelope proteins with the
R466G and K468G substitutions were inefﬁciently cleaved in the NIH
3 T3 cells.
In order to examine the surface expression of the R466G/Δ650–
665 and R466E/Δ650–665 Envs in NIH 3T3 cells a surface immuno-
ﬂuorescence assay was conducted. We found that the proteins were
expressed on the cell surface at a slightly reduced level as compared to
the Δ650–665 Env and the R466G and R466E full-length proteins
(Fig. 4B). These ﬁndings suggest that the R466G/Δ650–665 and
R466E/Δ650–665 proteins were expressed on the cell surface, but
were unable to promote syncytium formation, because of theirinefﬁcient processing. It is also possible that the transduction assay
is more sensitive than the syncytium-formation assay.
Uncleaved mutant glycoproteins retain capacity to bind to the receptor
Ecotropic murine leukemia viruses, such as Mo-MuLV, use the
rodent cationic amino-acid transporter-1 (CAT-1) as their cell surface
receptor (Albritton et al., 1989; Wang et al., 1991). It has been
demonstrated that endogenously produced MLV envelope protein
binds to CAT-1 and reduces its cell surface expression by affecting the
interaction between CAT-1 and clathrin adaptor complex-1 (AP-1)
(Fujisawa andMasuda, 2007). The reduced surface expression of CAT-
1 results in a reduction in superinfection by the same virus or a
different virus that uses the same receptor, a phenomenon known
as retroviral interference (Steck and Rubin, 1966). To demonstrate
that the substitution mutations created at the cleavage site of the
envelope protein do not affect the interactions between an endoge-
nously expressed envelope protein and the receptor protein, we
performed an interference assay. To perform this assay, stable clones
of NIH 3T3 were created that constitutively express the wild-type or
the uncleaved mutant envelope protein R469L or R466A/K468A. The
transduction of the cells was performed using recombinant ecotropic
Table 2
Syncytia formation promoted by mutant Mo-MuLV envelope proteins.
Mo-MuLV Env mutant Syncytia Formation (%)*
Wild-type (pen1minΔ650) 100
Neg. Cont. b0.25
R466A/Δ650-665 45±2
R466G/Δ650-665 b0.25
R466E/Δ650-665 b0.25
R466K/Δ650-665 73±3
K468A/Δ650-665 16±2
K468G/Δ650-665 b0.25
K468E/Δ650-665 b0.25
K468R/Δ650-665 102±7
R469A/Δ650-665 b0.25
R469G/Δ650-665 b0.25
R469E/Δ650-665 b0.25
R469L/Δ650-665 b0.25
R469K/Δ650-665 b0.25
E470A/Δ650-665 114±5
E470D/Δ650-665 128±7
E470G/Δ650-665 67±4
E470K/Δ650-665 b0.25
E470Q/Δ650-665 8±2
NIH 3 T3 cells were transiently transfected with plasmids encoding the mutant envelope
proteins lacking the last 16 amino acids at the carboxy-terminus. The number of syncytia
and the number of nuclei per syncytia were counted after 36 h of transfection. The
percentage of nuclei in syncytiawas calculated bymultiplying the total number of syncytia
by the average number of nuclei per syncytia and dividing by the total number of cells.
*The numbers in the table are normalized to the percentage of nuclei in syncytia formed
as a result of expression of wild-type envelope protein lacking the last 16 amino acids
(16%).
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employs Pit2, a sodium-dependent phosphate transporter (Tailor and
Kabat, 1997), as the receptor, was used as a control to demonstrate
that the transduction of NIH 3T3 cells was not generally affected by
constitutive expression of the envelope proteins. The transduction of
cells expressing the wild-type Env by recombinant ecotropic MLVwas
reduced by approximately 20-fold as compared to NIH 3T3 cells
expressing no Env. Transduction of the cells expressing R466A/K468A
and R469L was also reduced by ∼18–20-fold (Table 3). The trans-
duction of cells expressing mutant proteins remained similar to the
cells expressing no envelope protein when they were transduced
with the recombinant amphotropic MLV (Table 3) suggesting that
amphotropic-virus entry was not inhibited. Reduced transduction of
the cells expressing the mutant envelope proteins with the recom-
binant ecotropic MLV suggests that the mutant Envs are able to bind
to the receptor.
The intracellular distribution pattern of uncleaved glycoproteins is altered
The trafﬁcking of the mutant envelope proteins was addressed by
studying the intracellular localization of the protein by confocal
microscopy. We engineered a clone encoding an EGFP ﬂuorescent
marker protein at the C-terminus of the wild-type envelope protein
(pMolEnv-EGFP). The fusion protein exhibited normal processing
detected by an immunoblot assay using anti-SU (Fig. 5A) and anti-
EGFP antibody (data not shown) and virion incorporation (Fig. 5B).
Transduction by recombinant virus carrying the MolEnv-EGFP is
equivalent to that by virus carrying thewild-type Env, with the titer of
the virus carrying thewild-type Env being 6±0.2×106 and that of the
virus carrying TM-EGFP 5.8±0.2×106. In order to determine the
intracellular localization pattern of the incompletely cleaved and
uncleaved proteins the P4, P1 and P2–P4 paired substitutions were
inserted in the pMolEnv-EGFP. To study their intracellular localiza-
tion, the fusion proteins were transiently expressed in COS-7 cells.
Immunoblot analysis using anti-SU (Fig. 5C) and anti-GFP antibodies
(Data not shown) conducted on the cell lysates of mutant protein-
EGFP conﬁrmed that the EGFP remained fused to the glycoproteinupon expression in the cells. Forty hours after transfection, confocal
microscopy was performed to observe the EGFP ﬂuorescence.
Simultaneously, the localization pattern of the wild-type and mutant
envelope proteins was detected by an immunoﬂuorescence assay to
conﬁrm that EGFP fusion does not interfere with the protein
trafﬁcking and its localization. We found that cleaved proteins exhibit
a localization pattern similar to the wild-type Env, whereas uncleaved
proteins exhibited a localization pattern that was common to all the
uncleaved proteins (P1 and P2–P4 paired mutants) in COS-7 cells;
therefore we have shown here an example of P1 (R469L-EGFP). The
MolEnv-EGFP appeared to be evenly distributed in the cell and was
expressed on the cell surface (Fig. 5D). A Similar localization pattern
was observed in the case of R466G-EGFP. In contrast R469L-EGFP
appeared to be accumulated in the area surrounding the nucleus, in
what appeared to be the Golgi complex (Fig. 5D). These results were
conﬁrmed by colocalization studies of the fusion-protein with a Golgi
complex-speciﬁc ﬂuorescent marker-BODIPY (Fig. 5E). The TM-EGFP
and R466A-EGFP appeared to be distributed in the cell as well as on
the cell surface evenly, whereas, R469L-EGFP and R466A/K468A-EGFP
appeared to accumulate in the Golgi compartments, because the Env
fusion protein colocalized with BODIPY. These ﬁndings suggest that
only cleaved protein is transported to the site of assembly, whereas
the uncleaved envelope proteins are accumulated in the Golgi com-
partments. A colocalization study with a late endosomal/lysosome
speciﬁc antibody (LAMP-1) was also performed to determine the
presence of the envelope protein in the late endosomes. Our results
suggested that the envelope protein did not colocalize with LAMP-1
(data not shown).
Discussion
Although it has been established that cleavage of the envelope
protein into the SU and TM subunits is required for the infectivity of
many retroviruses, including MLV, HIV, and RSV, the cellular and
biochemical bases of the requirement have not been completely
elucidated (Bosch and Pawlita, 1990; Dubay et al., 1995; Famulari and
Jelalian, 1979; Freed et al., 1989; Freed and Risser, 1987; Herrera et al.,
2005; McCune et al., 1988; Perez and Hunter, 1987; Zavorotinskaya
and Albritton, 1999). Our results with the Mo-MuLV Env reinforce the
principle that cleavage between SU and TM is essential for function.
The sequence requirements at the cleavage site correspond to the
known substrate speciﬁcity of proprotein convertases (Henrich et al.,
2003, 2005; Remacle et al., 2008; Rockwell and Thorner, 2004). We
found that a positively charged amino acid, preferably an Arg, is
allowed at P1 for cleavage; such a residue can ﬁt well into a ﬂat groove
surrounded by acidic amino-acid residues in the S1 binding pocket of
furin (Henrich et al., 2003, 2005; Remacle et al., 2008; Rockwell and
Fuller, 2002; Rockwell et al., 2002; Rockwell and Thorner, 2004).
While a lysine or arginine is preferred at P2 and P4, the presence of
Ala, Gly, and Glu at P2 and P4 decrease the susceptibility of the protein
to proteolysis, with Glu substitutions being the most deleterious. Our
ﬁndings also suggest that an acidic residue is preferred for efﬁcient
cleavage at P1′, whereas Ala, Gly and Gln moderately decrease the
susceptibility. However, a lysine at P1′ completely abrogates cleavage.
These data are consistent with the positively charged S1′ subsite of
furin (Henrich et al., 2003, 2005; Remacle et al., 2008; Rockwell and
Thorner, 2004). Based on the site speciﬁc requirements of the enzyme
for cleavage indicated by our results, we conclude that furin is the
enzyme that cleaves the Mo-MuLV envelope protein. However, out
results (data not included) from studies on the cleavage pattern of the
wild-type envelope protein in LoVo cells (furin deﬁcient cells) or in
the presence of furin inhibitors suggested that other PCs can also
cleave Env in the absence of furin, but very inefﬁciently.
Our results also conﬁrm previous observations (Freed et al., 1989;
Freed and Risser, 1987) that substitution of Arg at P1 with a Lys
residue reduces the proteolytic processing and virus infectivity and
Fig. 4. A) Analysis of the proteolytic processing of the mutant envelope proteins lacking the R-peptide in NIH 3 T3 cells. The cell lysates of NIH 3 T3 cells expressing mutant envelope
proteins lacking the R-peptide were analyzed by immunoblot assay using anti-SU antibody and compared with the cell lysates expressing full-length envelope proteins carrying the
same substitutions. The positions of migration of gPr90env/Δ650-665 and gPr80env/Δ650-665, are indicated on the right and the positions of gPr80env and gp70(SU)* are indicated on
the left. The wild-type Env lacking the R-peptide (Env/Δ650-665) along with the full-length Env (wild-type) and mock are also shown. B) Cell-surface expression of the mutant
envelope proteins lacking the R-peptide in NIH 3 T3 cells. The cells transfected with envelope protein mutants were ﬁxed with 0.4% formaldehyde and probed with anti-SU 83A25
antibody and alexa-488 conjugated secondary antibody. The cell surface expression of the protein was visualized by a confocal microscope.
Table 3
Cellular receptor binding by mutant Mo-MuLV envelope proteins.
Mutant envelope proteins ΦNX-Eco Titer
(TU/ml)
ΦNX-Ampho Titer
(TU/ml)
NIH 3 T3 not expressing any
envelope protein
5.1±0.1×106 5.1±0.10×106
NIH 3 T3 expressing wild-type
envelope protein
2.6±0.11×105 5.1±0.14×106
R469L 2.7±0.13×105 5.1±0.17×106
R466A/K468A 2.6±0.12×105 5.1±0.15×106
NIH 3 T3 cells were stably transfected with plasmids encoding wild-type, R469L and
R466A/K468Aenvelope proteinmutants. The cellswere infected by ecotropic-MLVvirus
produced by ΦNX-Eco and amphotropic-MLV produced by ΦNX-Ampho cells. Forty
eight hours after infection the cells were stained with X-gal and the percentage of blue
cellswas calculated. Transduction units/mlwas calculated bymultiplying the% blue cells
by total number of cells divided by total volume of virus-containing media (in ml).
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for cleavage. Additionally, the requirement of P2 and P4 basic amino
acids for cleavage in Mo-MuLV is similar to previous ﬁndings for the
HIV-1 (Bosch and Pawlita, 1990) and RSV Envs (Perez and Hunter,
1987).
Env protein cleavage appears to be required at two steps necessary
for viral infection. We have demonstrated by a syncytia-formation
assay that this cleavage is essential for membrane fusion. It was
induced only by the envelope proteins bearing an Arg at P1 and at least
one basic residue at either the P2 or P4 position. Additionally, it was
observed that Δ650–665 Envs with substitutions of the basic residues
at P2 or P4with Gly or Glu (R466G, R466E, K468G and K468E) reduced
membrane fusion to an undetectable level, even though the full-length
mutant Envswere able to promote transduction. Inefﬁcient processing
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mutant Δ650-665 proteins. The combination of reduced cell surface
expression, the incapacity of uncleaved Env to promote membrane
fusion and a difference in the sensitivity of the transduction and
syncytia assays is likely to have contributed to the observed results.
Unexpectedly SU–TM cleavage was also found to be required for
incorporation of the envelope protein into virus particles. Uncleaved
mutant envelope proteins were not present in the recombinant viral
particles. Indeed, the data provide evidence that there is rapid traf-
ﬁcking of cleaved Env proteins into budding virus; mutant Envs that
appeared to be inefﬁciently processed in cells were incorporated at
substantial levels into virus. Taking into account the microscopic
studies, in which Envs bearing substitutions in the cleavage motif
displayed aberrant localization, it can be concluded that there is a
reciprocal relationship between processing and trafﬁcking.
Previously it has been demonstrated that substitutions in a
putative receptor-binding region ofMuLV SU can reduce the efﬁciency
of Env cleavage (Zavorotinskaya and Albritton, 1999). It is of interest
that, albeit uncleaved Env molecules were observed to be incorpo-
rated into virus particles, cleaved Env was preferentially incorporated.
It was concluded that the cleaved Env molecules were responsible forFig. 5. Intracellular Localization of wild-type andmutant envelope protein: The proteins were
(B) virus incorporation of MolEnv-EGFP, and (C) expression of Env-EGFP mutants in cell ly
MolEnv-EGFP and Env-EGFP mutants was visualized by a ﬂuorescence microscope two days
with wt or uncleavedmutant protein expressing plasmid (Lower two panels). The cells were
Alexa-488 conjugated secondary antibody and visualized by a confocal microscope. (E) COS-7
trans-Golgi speciﬁc marker-BODIPY. Green ﬂuorescence of EGFP and red ﬂuorescence of th
green ﬂuorescence from EGFP, ‘BODIPY’ panels represent the cells stained with Golgi mark
MolEnv-EGFP represents wild-type envelope protein fused with EGFP and mock representsthe levels of viral entry determined (Zavorotinskaya and Albritton,
1999). There are two conceivable explanations for these results. Either
the uncleaved Envwas included in trimers containing a cleaved Env or
the identity of the P2 and P4 residues, left unperturbed, is the critical
factor in trafﬁcking as indicated by the present study.
It has been demonstrated previously that MLV Env packaging into
virus particles requires its interaction with Gag at the site of assembly
(Sandrin and Cosset, 2006). The inability of the uncleaved envelope
protein to be incorporated into virus particles may result from its
absence from membranes at the site of assembly. It can be speculated
that Env does not come in contact with Gag and therefore only naked
virus-like particles are released from the cells expressing cleavage-
defective Envs. Further experiments will be necessary to elucidate the
nature of the cellular factors that regulate uncleaved and cleaved Env
trafﬁcking to the site of assembly.
Conclusions
Overall, this study provides strong evidence for the proteolytic
cleavage of the glycoprotein in its biological role. Many protease-
based inhibitors have been investigated and several furin inhibitorsexpressed in COS-7 cell culture. (A) MolEnv-EGFP protein expression in the cell lysates,
sates were detected by immunoblot assay using anti-SU antibody. (D) Fluorescence of
after transfection (upper two panels) or by immunoﬂuorescence of the cells transfected
ﬁxed and permeabilizedwith TritonX-100 and probedwith anti-SU 83A25 antibody and
cells expressing wild-type andmutant Env-EGFP fusion proteins were probed with the
e Golgi marker was detected using a confocal microscope. ‘EGFP’ panels represent the
er, and the ‘Merged’ panels represent the merge between EGFP and the Golgi-marker.
cells transfected with TE buffer and stained with the Golgi marker.
Fig. 5 (continued).
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as HIV-1 (Kibler et al., 2004), measles virus F0 (Watanabe et al., 1995),
Human Cytomegalovirus (François Jean et al., 2000), respiratory
syncytial virus (Basak et al., 2001), and bacterial toxins such as P.
aeruginosa exotoxin (Sarac et al., 2002) and anthrax (Henrich et al.,
2003). Additional research in this direction should lead to further
understanding of the virus assembly as well as new ways of blocking
Env cleavage and trafﬁcking.
Materials and methods
Cell lines and cell culture
Human embryonic-kidney 293T-based ΦNXgp cells and COS-7
cells were obtained from the American Type Culture Collection (ATCC)
(Rockville, MD). ΦNXnlslacZ cells, which produce replication-incom-
petent, envelope protein-deﬁcient, Mo-MuLV particles that contain
MFG.S-nlslacZ, a retroviral vector encoding a nuclear-localized β-
galactosidase (Ory et al., 1996; Sharkey et al., 2001),ΦNX-Ampho, the
amphotropic-MLV producing cell line, and ΦNX-Eco, the ecotropic-MLV producing cells were cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM; Sigma) containing 10% fetal bovine serum (FBS;
Sigma), penicillin (10 U/ml) and streptomycin (0.1 mg/ml) (PS; Sigma)
(DMEM/FBS/PS) at 37 °C in the presence of 5% CO2. Mouse NIH 3T3
ﬁbroblast cells were cultured in DMEMwith 10% calf serum (CS; Gibco-
BRL) and 1% PS (DMEM/CS/PS).
Construction of plasmids encoding mutant Mo-MuLV envelope proteins
For the cleavage-site mutants a pMoenv+1 min BglII463 plasmid
was createdwhere a TCC codonwas changed to TCT to introduce a BglII
site at the amino-acid position 463. The plasmid was digested with
BglII and AgeI and ligated with double-stranded oligonucleotides
encoding the mutations. The BstEII and ClaI fragments of the envelope
genes were inserted into the Mo-MuLV Env expression plasmids,
penv1min (encodingwild-type Env) and penv1minΔ650–665 (encod-
ing Env lacking the C-terminal 16 residues (Taylor and Sanders,
1999)). pMolEnv-EGFP (encoding an enhanced green ﬂuorescent
protein (EGFP) fused to the envelope protein)was created by inserting
the EGFP open reading frame at the 3′ end of env in penv1min using
223S. Apte, D.A. Sanders / Virology 405 (2010) 214–224BamHI and EcoRI restriction sites. The ClaI/BstEII fragments of mutant
penv1min plasmidswere ligated into pMolEnv-EGFP digestedwith the
same restrictions enzymes.
Transfection, viral transduction and syncytia-formation assay
The penv1min plasmid encoding thewild-type or amutant envelope
proteinwas transiently transfected intoΦNXnlslacZ cells by themethod
previously described with the following modiﬁcations (Taylor and
Sanders, 1999). The plasmid DNA (3 μg) was mixed with 250 μl DMEM
and 8 μl Plus reagent (Invitrogen) and incubated for 15 min at 25 °C. In a
separate tube 12 μl of LipofectAMINE (Invitrogen) was diluted with
250 μl DMEM. The DNA and LipofectAMINE solutions were mixed,
incubated for 15 min at RT and then added to 8 ml of DMEM/FBS/PS.
TheDNA–LipofectAMINE–culturemediummixturewasadded to4×106
cells on a 10 cm tissue culture dish. Viral transduction into NIH 3T3 cells
and staining for β-galactosidase activity were determined according to
the protocol previously described (Taylor and Sanders, 1999). The
syncytia-formation assaywas performedby transiently transfectingNIH
3T3 cells with the penv1minΔ650–665 plasmid encoding the mutant
envelope proteins as described (Taylor and Sanders, 1999).
Immunoblotting and PNGaseF analysis
Immunoblot analysis of proteins present in lysates of transfected
cells and in virions in the culturemediumwas conductedwith goat anti-
Rauscher leukemia virus (RLV) gp71/gp69polyclonal antibody(1:1000)
(ATCC # VR1519AS-Gt) and HRP-conjugated chicken anti-goat second-
ary antibody (1:5000) (Chemicon), rat anti-TM p15E antibody 10CE11
(1:1000) (kindly provided by A. Pinter (Li et al., 1997)) and goat anti-rat
HRP-conjugated antibody (1:5000) as previously described (Taylor and
Sanders, 2003). When antibody against capsid protein was used,
membranes were probed using goat anti-RLV p30 antiserum (1:1000)
(Quality Biotech). Half of the cell lysates were used for PNGaseF enzyme
(New England Biolabs) treatment according to the protocol provided
by the supplier. The protein samples were subjected to immunoblot
analysis using goat anti-RLV gp71/gp69 antibody (1:1000) and chicken
anti-goat secondary antibody (1:5000).
Stable cell lines and interference assay
NIH 3T3 cellswere stably transfectedwith the full-length expression
vector penv1min carrying wild-type, R469L or R466A/K468A mutants,
as previously described (Taylor and Sanders, 1999). The viral interfer-
ence assay was performed according to the protocol described earlier
(Taylor and Sanders, 1999). Brieﬂy, ecotropic-MLV producing cells,
ΦNX-Eco, and amphotropic-MLV producing cells, ΦNX-Ampho, were
transiently transfected withMFG.S-nlslacZ, a retroviral vector encoding
a nuclear-localized β-galactosidase (Ory et al., 1996; Sharkey et al.,
2001). The supernatant was added to 5×105 cells and virus titer was
calculated 48 h after transduction.
Immunoﬂuorescence assay and microscopy
COS-7 cells (1×105 cells) were seeded onto a cover glass #2 (18×
18 mm) in a 6-well plate 24 h before transfection. The cells were
transfected with pMolEnv-EGFP encoding either wild-type or mutant
Env–EGFP fusion protein. After 40 h, the cells were washed with 1X
phosphate-buffered saline (PBS), and the coverslips were mounted in
FluoroSafe mounting medium (Calbiochem, San Diego, CA). The ﬂuo-
rescence emission of EGFP from cells was observed using the 60X oil-
immersionobjectiveof a Zeiss-1024 confocal laser scanningmicroscope.
Green emission was observed by exciting the ﬂuorophore with a 488-
nm laser. For colocalization studies, the cells were incubated with
organelle-speciﬁc markers for 1h at 37 °C 40h after transfection. Golgi-
speciﬁc marker BODIPY® TR C5-ceramide complexed to BSA (0.5 mg/ml) that emits red ﬂuorescence (Molecular Probes, OR), and late
endosome/lysosome speciﬁc marker LAMP-1 conjugated with phyco-
erythrin was used for live cell imaging.
For the immunoﬂuorescence assay the cells were ﬁxed with 4%
formaldehyde for 10 min at room temperature, treated with 50 mM
ammonium chloride for 10 min, and then blocked with 1% BSA for
15 min at 37 °C. When permeabilized, the cells were incubated with
0.25% TritonX-100 for 10 min at room temperature after the formalde-
hyde treatment. Cells were incubated with primary monoclonal anti-
body, 83A25 (Kind gift of L.H. Evans) in 1%BSA (1:2 dilution) for 1 h and
after three washes in PBS, incubated with anti-rat secondary antibody
conjugated with alexa-488 (1:500 dilution) for 1 h at 37 °C. The nuclei
were stainedwith propidium iodide for 5 min at room temperature. The
coverslips were inverted onto the slides in FluoroSafe solution, and
confocal microscopy was performed.
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